Innovation Pharmaceuticals Inc. (IPIX)

IPIX Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Revenue	-	-	0.02	-	0.42	-
Gross Profit	-	-	0.02	-	0.42	-
Selling, General & Admin	1.49	1.48	1.96	2	2.27	1.95
Research & Development	0.87	1.46	4.81	7.02	2.79	4.34
Operating Expenses	2.36	2.94	6.78	9.02	5.06	6.3
Operating Income	-2.36	-2.94	-6.76	-9.02	-4.64	-6.3
Interest Expense	-0.06	-0.06	-0.12	-4.86	-0.26	-2.2
Earnings From Equity Investments	-0.21	-0.17	-0.02	-	-	-
Other Non Operating Income (Expenses)	-	-	-0.18	-	0.1	0.36
EBT Excluding Unusual Items	-2.62	-3.17	-7.07	-13.87	-4.79	-8.14
Asset Writedown	-	-	-0.14	-	-0.64	-0.15
Other Unusual Items	-	-	0.17	-	-1.21	-0.39
Pretax Income	-2.62	-3.17	-7.04	-13.87	-6.65	-8.68
Net Income	-2.62	-3.17	-7.04	-13.87	-6.65	-8.68
Net Income to Common	-2.62	-3.17	-7.04	-13.87	-6.65	-8.68
Shares Outstanding (Basic)	509	506	504	386	238	178
Shares Outstanding (Diluted)	509	506	504	386	238	178
Shares Change (YoY)	-1.42%	0.38%	30.48%	61.96%	33.78%	23.33%
EPS (Basic)	-0.01	-0.01	-0.01	-0.04	-0.03	-0.05
EPS (Diluted)	-0.01	-0.01	-0.01	-0.04	-0.03	-0.05
Free Cash Flow	-1.99	-2.11	-6.28	-9.5	-4.16	-6.33
Free Cash Flow Per Share	-0.00	-0.00	-0.01	-0.03	-0.02	-0.04
Gross Margin	-	-	100.00%	-	100.00%	-
Operating Margin	-	-	-37544.44%	-	-1095.74%	-
Profit Margin	-	-	-39116.67%	-	-1571.63%	-
Free Cash Flow Margin	-	-	-34888.89%	-	-982.51%	-
EBITDA	-1.99	-2.57	-6.38	-8.64	-4.26	-5.93
D&A For EBITDA	0.37	0.37	0.38	0.38	0.37	0.37
EBIT	-2.36	-2.94	-6.76	-9.02	-4.64	-6.3

Updated Nov 20, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.